Dosage regimen comprising ap02l/trail, anti-vegf / anti-cd20 and chemotherapy to treat nsclc or non-hodgkin's lymphoma, respectively

The invention provides methods of treating non-small cell lung cancer (NSCLC) and non-hodgkin's lymphoma (NHL). The methods include treating cancer cells with an effective amount of Apo2L/TRAIL and selected chemotherapy regimines and antibody therapies. Articles of manufacture and kits comprising Apo2L/TRAIL and package inserts that provide, eg, administration and dosing information for treating cancers such as NSCLC and NHL are also included.